Palto Therapeutics
PrivateCompany Overview
Palto Therapeutics is a drug discovery company that develops novel formulations for biological drugs, such as siRNAs, to enable direct and exclusive delivery to diseased cells and tissues.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
siRNA deliverydrug deliverytargeted drug deliveryRNAi therapeuticsnanoparticle deliveryRNA therapeuticsdrug formulationoligonucleotide deliverygenetic medicinescancer therapeuticsoncologypancreatic cancerrare diseasesdrug discoveryprecision medicine
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Palto Therapeutics Comparables
Compare Palto Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cession Oncology | 84% | |
| Argo Biopharma | 78% | |
| Sirnaomics | 66% | |
Palto Therapeutics Funding Rounds
Historical fundraising activity
Palto Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Palto Therapeutics's valuation, stock price, and market status.
See something wrong or outdated?